SynthesisFrontiers in oncology2021

Progression-Free Survival as Early Efficacy Endpoint in Resectable Esophageal Cancer Treated With Neoadjuvant Therapy: A Systematic Review.

Jie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.